Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2025-12-26 @ 10:17 PM
NCT ID:
NCT03483012
Group ID:
EG000
Title:
Atezolizumab + Stereotactic Radiosurgery (SRS)
Description:
* Atezolizumab administered intravenously once every 3 weeks
* Stereotactic radiosurgery (SRS) begin within 14 days after brain MRI obtained
Atezolizumab: Atezolizumab is a protein that affects your immune system by blocking the PD-L1 pathway
Stereotactic radiosurgery (SRS): Stereotactic radiosurgery (SRS) is a standard procedure used to treat patients with cancer in the brain. SRS uses many precisely focused radiation beams to treat tumors
Deaths Number Affected:
5
Deaths Number At Risk:
None
Serious Number Affected:
2
Serious Number At Risk:
6
Other Number Affected:
5
Other Number At Risk:
6
Study:
NCT03483012
Results Section:
NCT03483012
Adverse Events Module:
NCT03483012